Technical Analysis for CSL - CSL Limited
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bullish Centerline Cross | Bullish | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
BB Squeeze Ended | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Overbought Stochastic | Strength | 0.00% | |
Crossed Above 50 DMA | Bullish | 0.55% | |
Bollinger Band Squeeze | Range Contraction | 0.55% | |
Stochastic Reached Overbought | Strength | 0.55% | |
BB Squeeze + Upper Band Touch | Range Contraction | 0.55% |
Alert | Time |
---|---|
Up 1% | about 16 hours ago |
Rose Above Previous Day's High | about 18 hours ago |
Up 1 ATR | 1 day ago |
Possible NR7 | 1 day ago |
Rose Above 50 DMA | 1 day ago |
Get a Trading Sidekick!
CSL Limited Description
CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Biotechnology Intellectual Property Biopharmaceutical Therapeutic Product Therapeutic Products Pharmaceutical Products In Vitro Pharmacology Diagnostic Products
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 308.8426 |
52 Week Low | 227.2563 |
Average Volume | 712,048 |
200-Day Moving Average | 267.934 |
50-Day Moving Average | 285.960 |
20-Day Moving Average | 281.267 |
10-Day Moving Average | 281.548 |
Average True Range | 3.980 |
RSI (14) | 59.02 |
ADX | 13.48 |
+DI | 30.018 |
-DI | 16.540 |
Chandelier Exit (Long, 3 ATRs) | 277.821 |
Chandelier Exit (Short, 3 ATRs) | 286.939 |
Upper Bollinger Bands | 286.574 |
Lower Bollinger Band | 275.961 |
Percent B (%b) | 1.13 |
BandWidth | 3.773 |
MACD Line | 0.005 |
MACD Signal Line | -1.018 |
MACD Histogram | 1.0229 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 292.090 | ||||
Resistance 3 (R3) | 292.240 | 291.000 | 291.395 | ||
Resistance 2 (R2) | 291.000 | 289.938 | 290.925 | 291.163 | |
Resistance 1 (R1) | 289.460 | 289.282 | 288.840 | 289.310 | 290.932 |
Pivot Point | 288.220 | 288.220 | 287.910 | 288.145 | 288.220 |
Support 1 (S1) | 286.680 | 287.158 | 286.060 | 286.530 | 284.908 |
Support 2 (S2) | 285.440 | 286.502 | 285.365 | 284.677 | |
Support 3 (S3) | 283.900 | 285.440 | 284.445 | ||
Support 4 (S4) | 283.750 |